TCL Archive NCI Funding Plan For 1983: 20% Cut From Recommended Levels for All Grants, Change In Program Projects October 8, 1982
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
